<DOC>
	<DOCNO>NCT00921830</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetic bioavailability characteristic two test formulation ibuprofen rectal administration profile market reference formulation ibuprofen 200 mg ( oral administration ) .</brief_summary>
	<brief_title>Pharmacokinetics 3 Formulations Ibuprofen Suppositories</brief_title>
	<detailed_description>Ibuprofen widely use analgesic antipyretic adult child . Two ibuprofen suppository formulation develop pediatric use facilitate dosing young age group . This single-dose , balance , randomise , three-period crossover study healthy male female adult volunteer . Each volunteer receive single dose 50 mg ibuprofen suppository , single dose 200 mg ibuprofen suppository single oral dose 200 mg ibuprofen ( tablet ) . There 14 blood sample take 12 hour study period . Concentrations plasma ibuprofen S R enantiomer measure use validated chromatographic method . Standard pharmacokinetic parameter obtain bioavailability basis rate extent drug absorption assess .</detailed_description>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Healthy male female volunteer age 18 55 year BMI &lt; 27 kg/m2 Nonsmokers , smoker less 10 cigarette per day Clinically normal vital sign Clinically normal medical history Clinically normal finding physical examination Clinically normal finding haematology clinical chemistry blood urine show clinically insignificant deviation Screening result drug abuse ( take within 14 day study start ) must negative opiate , cannabinoids , amphetamine , methamphetamine , benzodiazepine cocaine HIV Hepatitis B C test , take within previous 14 day study start , must negative Appropriate use effective method contraception ( female volunteer ) . Use oral contraceptive pill permit Ability comprehend communicate effectively Investigator staff Ability give write informed consent Electrocardiogram recording ( 12lead ) within normal range History peptic ulcer gastrointestinal bleeding Resting heart rate outside range 50 90 beat per minute exhibit clinically significant degree heart block Resting , seat blood pressure le 100/60 ( 90/50 female ) great 140/90 mmHg Clinically significant electrolyte imbalance Evidence clinically significant cardiovascular , haematological , hepatic , gastrointestinal , renal , respiratory , neurological , psychiatric disease History medication psychopharmacologically active agent within last five year ( occasional night sedative ) Gastric bleed history allergy NSAIDs History psychiatric illness clinical treatment psychiatric illness within last five year History epilepsy History significant drug drug relate hypersensitivity/intolerance food allergy Illness within 14 day prior start study Hospitalisation within previous 3 month major surgery significant medical illness ( discretion Investigator ) Mental handicap define clinical evaluation Tobacco smoking 10 cigarette per day Participation clinical drug study blood take within 16 week prior start study Donation blood plasma within previous 90 day Participation clinical trial previous 12 month volume blood exceed 500 ml donate Any indication current previous abuse alcohol , solvent drug Treatment full regular course medication 28 day prior start study Use alcohol study day within 24 hour prior commencement study period Intake grapefruit product within 7 day prior study commencement Intake methylxanthinecontaining beverage within 24 hour prior study period Intake quantity methylxanthine alcoholcontaining beverage , opinion Investigator abnormal ( habitually take 5 cup glass tea , coffee , cola , chocolate etc per day habitually take 20g alcohol/day ) Taking medication ( prescription proprietary ) within 14 day prior study start . Paracetamol allow 72 hour prior either study period . The oral contraceptive pill allow . Failure use adequate contraceptive measure ; positive pregnancy test ( female volunteer ) Lactating/breastfeeding ( female volunteer ) Diet , opinion Investigator , deviate normal diet ( e.g . vegan ) Not able/not willing give inform consent Not able contacted case emergency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>ibuprofen</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>bioavailability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>suppository</keyword>
</DOC>